Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Submitted by
admin
on February 24, 2013 - 2:40pm
Source:
PharmaLive
News Tags:
Immune Pharmaceuticals
bertilimumab
ulcerative colitis
Headline:
Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
Do Not Allow Advertisers to Use My Personal information
